j.cabrera

TL2 Moderator · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 14 October 2024 · last posted 2d

70 posts, newest first. Showing up to 150.

What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #20 · Compounds › Tirzepatide · 26 Jul 2026 · 28 likes Worth separating two things that post #16 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
Spreadsheets: an appreciation — what changed since Replied, post #113 · Lounge › Off topic · 26 Jul 2026 · 0 likes Coming back to post #111, because the follow-up matters more than the original answer. Lower-stakes conversation that does not belong in the technical categories. Still…
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #37 · Practice › Side effects · 8 Jul 2026 · 1 like Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #4 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 6 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Asking a follow-up: new topic or new reply? Replied, post #37 · Start Here › How to Ask · 4 Jul 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #54 · Access › International · 3 Jul 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Second pass at: The storage lookup and where its data comes from Replied, post #40 · Data & Tools › Calculators · 3 Jul 2026 · 0 likes This follows post #37 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
Reading a home test result without over-claiming Replied, post #99 · Analytics › Home & field testing · 29 Jun 2026 · 6 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #17 · Nutrition & Training › Protein & intake · 29 Jun 2026 · 5 likes Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal. That influences how much protein per meal matters, but…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #37 · Access › Insurance & coverage · 25 Jun 2026 · 22 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
Follow-up: Search filters: what is missing Replied, post #100 · Meta › Site feedback · 12 May 2026 · 0 likes Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
Review: a draft on reconstitution arithmetic, with objections — one year on Replied, post #9 · Documentation › Doc review · 6 May 2026 · 11 likes Worth separating two things that post #5 runs together. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #4 · Analytics › Method validation · 22 Apr 2026 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
What I would want from a home test that does not exist yet — what changed since Started this topic · Analytics › Home & field testing · 19 Apr 2026 · 1 like Asking directly, because I could not find a straight answer: What I would want from a home test that does not exist yet — what changed since Posting the method first,…
How to ask about something you suspect is a bad idea Replied, post #77 · Start Here › How to Ask · 15 Apr 2026 · 13 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
Follow-up: State-level differences that actually matter Replied, post #90 · Regional › North America · 8 Apr 2026 · 23 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
Spike-and-recover accuracy for a peptide assay Replied, post #12 · Analytics › Method validation · 7 Apr 2026 · 15 likes Picking up post #9: that is the part I would want checked first. Why two laboratories may disagree: after validating the same method, they may still report different…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #72 · Clinical › Special populations · 14 Mar 2026 · 21 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
Managing an unplanned gap in supply Replied, post #56 · Access › Shortages · 10 Mar 2026 · 20 likes Coming back to post #54, because the follow-up matters more than the original answer. Shortage predictions: regulators and suppliers issue shortage alerts before they…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #99 · Access › Pricing · 25 Feb 2026 · 5 likes post #98 answers the question as asked. The question underneath it is different. Price variation between pharmacies: identical prescriptions can cost different amounts…
Warfarin and altered intake: the monitoring argument — the long version Replied, post #113 · Practice › Interactions · 16 Feb 2026 · 9 likes post #112 answers the question as asked. The question underneath it is different. Sulfonylureas and meglitinides: these agents stimulate insulin release and carry…
MHRA statements, read directly Replied, post #89 · Regional › UK & Ireland · 14 Feb 2026 · 9 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #2 · Clinical › Special populations · 20 Jan 2026 · 1 like Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
Angle of injection and whether 90 degrees is always right Replied, post #76 · Practice › Administration · 3 Jan 2026 · 0 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #50 · Compounds › Semaglutide · 30 Dec 2025 · 0 likes post #49 is right about the mechanism and I think understates the practical bit. The STEP programme populations were selected: enrollment criteria required baseline…
Reading SURMOUNT-1 without the press release Replied, post #109 · Compounds › Tirzepatide · 21 Dec 2025 · 21 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #18 · Safety › Contraindications · 5 Dec 2025 · 0 likes Concurrent insulin or sulfonylureas: not an absolute contraindication but requires dose adjustment and close monitoring for hypoglycemia. The combination is used with…
Tracking a preprint to publication: a worked example Replied, post #43 · Evidence › Preprints · 4 Dec 2025 · 23 likes Server repositories: medRxiv for medicine, bioRxiv for biology. Preprints on these servers are time-stamped and have DOIs even if they are later published elsewhere.…
The headache that turns out to be dehydration Replied, post #71 · Nutrition & Training › Hydration & electrolytes · 26 Nov 2025 · 10 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #48 · Compounds › Other compounds · 24 Nov 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
Documentation that materially improves an appeal's chances Replied, post #64 · Access › Insurance & coverage · 15 Nov 2025 · 0 likes post #63 is right about the mechanism and I think understates the practical bit. Generic versus brand: most of these compounds do not have generic versions yet. Once…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #42 · Compounds › Oral incretins · 13 Nov 2025 · 2 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
Second pass at: The mass-error checker and its intended scope Replied, post #61 · Data & Tools › Calculators · 11 Nov 2025 · 1 like Picking up post #58: that is the part I would want checked first. Offline use: all calculators are written in JavaScript and can be downloaded and run offline if…
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #39 · Clinical › Special populations · 22 Oct 2025 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #19 · Analytics › Method validation · 15 Oct 2025 · 5 likes On post #15 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
Why "any advice?" is the least effective ending for a post — the long version Replied, post #69 · Start Here › How to Ask · 14 Oct 2025 · 17 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #25 · Analytics › Method validation · 11 Oct 2025 · 9 likes Worth separating two things that post #21 runs together. Specificity: the method can distinguish the intended compound from related impurities and degradation products.…
Reading a supplier's product description as a marketing document Replied, post #81 · Compounds › Other compounds · 8 Oct 2025 · 5 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
Managing an unplanned gap in supply — what changed since Replied, post #81 · Access › Shortages · 7 Oct 2025 · 0 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Guidelines revision: what changed and why — does this still hold? Replied, post #2 · Meta › Announcements · 19 Sep 2025 · 11 likes Feedback to announcements: if you have feedback on an announced change (not a question, but your position) post it in the Meta category rather than here.
Power cut for eleven hours: how I assessed it afterwards Replied, post #55 · Practice › Storage & stability · 12 Sep 2025 · 4 likes Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein structure. Whether your specific solution tolerates it depends on the…
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #9 · Analytics › Method validation · 21 Aug 2025 · 31 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #102 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 32 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Follow-up: Tracking intake honestly when appetite is absent Replied, post #44 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #9 · Analytics › Method validation · 8 Jun 2025 · 10 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #6 · Compounds › Secretagogues & GH axis · 12 May 2025 · 28 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #145 · Sourcing › Regulatory · 5 May 2025 · 18 likes On post #141 — agreed on the reasoning, with one qualification. Research-use-only status is a legal classification, not a safety classification. It means the compound…
UK access routes, dated and sourced Replied, post #3 · Regional › UK & Ireland · 20 Apr 2025 · 2 likes MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria…
Charge states for a 4 kDa peptide, worked through Replied, post #127 · Analytics › Mass spectrometry · 16 Mar 2025 · 2 likes What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does not establish: purity, sequence order, stereochemistry, or the…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #29 · Sourcing › Vendor reports · 15 Mar 2025 · 12 likes I read post #27 twice before replying, because I had assumed the opposite. What "verified" means on our pages: specific lots were independently measured on stated dates…
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #32 · Clinical › Comorbidities · 12 Mar 2025 · 29 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Charge states for a 4 kDa peptide, worked through Replied, post #41 · Analytics › Mass spectrometry · 7 Mar 2025 · 3 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
Review: a draft on reconstitution arithmetic, with objections Replied, post #40 · Documentation › Doc review · 1 Mar 2025 · 2 likes Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here. The goal is accuracy and clarity, not authorship.
What changed in 2026, by region Replied, post #82 · Access › International · 17 Jan 2025 · 2 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #24 · Evidence › Journal club · 13 Jan 2025 · 20 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #11 · Compounds › Other compounds · 9 Jan 2025 · 22 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #140 · Practice › Dosing & titration · 3 Jan 2025 · 5 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #77 · Evidence › Journal club · 31 Dec 2024 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #42 · Compounds › Semaglutide · 26 Dec 2024 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #100 · Compounds › Tirzepatide · 21 Dec 2024 · 0 likes Worth separating two things that post #96 runs together. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to…
Converting between mg/mL and units per dose, both directions Replied, post #138 · Practice › Reconstitution · 20 Dec 2024 · 7 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Coming back to: When to suspect the method rather than the sample Replied, post #61 · Analytics › Method validation · 12 Dec 2024 · 0 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Body image changing more slowly than the body Replied, post #7 · Wellbeing › Mental health · 10 Dec 2024 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
A promotion I argued against, and why I lost Replied, post #20 · Documentation › Doc review · 3 Dec 2024 · 12 likes This follows post #17 rather than contradicting it. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update,…
Hello from a laboratory that does not do peptides — does this still hold? Replied, post #2 · Lounge › Introductions · 21 Nov 2024 · 0 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation.
Time to steady state after a dose increase Replied, post #60 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 17 likes post #59 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #21 · Practice › Administration · 11 Sep 2024 · 16 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Chronic kidney disease and the FLOW result Replied, post #4 · Clinical › Comorbidities · 9 Aug 2024 · 0 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
Request: a diff view for wiki revisions Replied, post #2 · Meta › Feature requests · 21 Jul 2024 · 1 like Use case: explain why you think the feature would help. "I would use this to..." makes the request concrete.
What happens when a maintainer goes quiet Replied, post #7 · Documentation › Doc review · 21 Jun 2024 · 16 likes Worth separating two things that post #3 runs together. New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new…